Industry Pharmaceuticals (See Other Companies in Industry)
855 Boylston Street 11th Floor| Date | Filing Type | Offered | Sold | Type | Link to Raw Filing |
|---|---|---|---|---|---|
| 2012-12-04 | Amended | Offered: $42,500,000 | Sold: $22,500,000 | Type: Equity Only | Raw Filing |
| 2012-06-04 | New Form D | Offered: $34,500,000 | Sold: $9,500,000 | Type: Equity Only | Raw Filing |
| 2010-08-30 | Amended | Offered: $40,000,000 | Sold: $18,000,000 | Type: Equity Only | Raw Filing |
| 2010-03-22 | New Form D | Offered: $21,000,000 | Sold: $10,000,000 | Type: Equity Only | Raw Filing |
| Name | Role | Address |
|---|---|---|
| Christian De La Tour | Director | C/O Ipsen Biopharm Ltd. 190 Bath Road Slough, X0, SL1 3XE |
| Todd Foley | Director | C/O Mpm Capital, Llc 200 Clarendon Street 54th Floor Boston, MA, 02116 |
| Keith Gottesdiener | Director, Executive | 855 Boylston Street 11th Floor Boston, MA, 02116 |
| Bart Henderson | Executive | 855 Boylston Street 11th Floor Boston, MA, 02116 |
| Vaughan Kailian | Director | C/O Mpm Capital, Llc 200 Clarendon Street, 54th Flr. Boston, MA, 02116 |
| Edward Mathers | Director | C/O New Enterprise Associates 1119 St. Paul Street Baltimore, MD, 21202 |
| Steven St. Peter | Director | C/O Mpm Capital, Llc 200 Clarendon Street 54th Floor Boston, MA, 02116 |
| Lou Tartaglia | Director | C/O Third Rock Ventures, L.P. 29 Newbury Street Boston, MA, 02116 |